[Combination hemodilution and defibrinogenating therapy in chronic arterial occlusive diseases].
D000721:Ancrod / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001809:Blood Viscosity / Q000187:drug effects; D002986:Clinical Trials as Topic; D003911:Dextrans / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004903:Erythrocyte Aggregation / Q000187:drug effects; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D010100:Oxygen; D010313:Partial Pressure
D003911:Dextrans; D005340:Fibrinogen; D000721:Ancrod; D010100:Oxygen
Kombinierte hämodilutierende und defibrinogenierende Therapie chronischer arterieller Verschlusserkrankungen.